CURRICULUM VITAE - Bucci Laser VisionASCRS) Symposium, San Diego, CA, April, 2007 Best Poster of...

$: CURRICULUM VITAE - Bucci Laser VisionASCRS) Symposium, San Diego, CA, April, 2007 Best Poster of Conference - Annual Meeting of the American Society of Cataract and Refractive Surgery$
1

CURRICULUM VITAE

FRANK A. BUCCI, JR., M.D.

1970 - 1974 Rollins College, Winter Park, Florida

B.A. Economics - Full Basketball Scholarship

1974 - 1976 Account Executive, Construction Materials Division, Lehigh Portland

Cement Company, Orlando, Florida

1976 - 1978 Cornell University, Robert Wood Johnson Graduate School of

Management, Ithaca, New York

M.P.A. in Health Care Administration

1978 - 1980 University of Florida, Gainsville, Florida

Post-Baccalaureate Premed Program (GPA 3.9)

1981 - 1985 Rutgers Medical School, Newark, New Jersey

M.D. awarded May, 1985

1985 - 1986 Jersey Shore Medical Center, Neptune, New Jersey

Transitional Resident

1986 - 1989 Albany Medical Center Hospital, Albany, New York

Resident in Ophthalmology

1989 - 1990 University of Minnesota, Minneapolis, Minnesota

Fellowship in Cornea and External Disease, Refractive Surgery, and Small

Incision Cataract Surgery (Drs. Lindstrom, & Holland)

1990 - 1992 Corneal Consultants of Ohio, Sylvania, Ohio

1992 - 1998 The Pugliese Eye Specialists, Kingston, PA

1995 - 2000 Adjunct Staff, Wills Eye Hospital, Philadelphia, PA

1998 - Present Founder, Bucci Laser Vision Institute & Ambulatory Surgery Center

Wilkes-Barre, PA

2003 - Present Founder, Chairman of the Board, and President, Hospice of the Sacred

Heart, Wilkes Barre, PA

2007 - Present Founder and Partner, Instituto de Ojos Sacro Cuore, Miraflores,

Lima, Peru

2008 - Present Senior Medical Director for Physician Recommended Nutriceuticals,

Plymouth Meeting, PA

2

Scholarships and Awards:

Full Four-Year Athletic Scholarship (Basketball)

Omicron Delta Kappa Leadership Award

Captain 1973-1974 NCAA Eastern Regional Basketball Champions

The 1986 Publication Award – Annual Publications Award

Competition, Jersey Shore Medical Center

Robert D. Reinecke Award 1988 (Outstanding Research by Resident in Ophthalmology)

Best Scientific Poster - Annual Meeting of Contact Lens Associates of Ophthalmology (CLAO),

January, 1990

Fisons Corporation Grant for Ophthalmic Contact Lens and Immunology Research - Annual Meeting of

Contact Lens Association of Ophthalmology (CLAO), January, 1992




January, 1994




January, 1995

Best Paper of Session - Annual Meeting of the American Society of Cataract and Refractive Surgery

(ASCRS) Symposium, San Diego, CA, April, 2007

Best Poster of Conference - Annual Meeting of the American Society of Cataract and Refractive

Surgery (ASCRS) Symposium, San Diego, CA, April, 2007

American Academy of Ophthalmology’s (AAO) Achievement Award, May, 2007

Speaker of the Day - Royal Hawaiian Eye 2008, Physicians Program, January 21, 2008

The Times Leader Health Care Hero, 2009

Governor Robert P. Casey Medal for a Lifetime of Service 2012

3

Organizations and Licensure: Diplomate, American Board of Ophthalmology

Member, American Medical Association

Member, American Academy of Ophthalmology/International Society of Refractive Surgery

Member, Association for Research and Vision in Ophthalmology

Diplomate, National Board of Medical Examiners

Ocular Microbiology and Immunology Group

Contact Lens Association of Ophthalmology

American Society of Cataract and Refractive Surgeons

Castroviejo Cornea Society

Medical Advisory Board, Northeast PA Lions Eye Bank, Bethlehem, PA

Publications:

1. Bucci, F.A., Jr. and Weiner, B.D.: The Pyogenic Granuloma. Arizona Medicine 41:794- 796,

1984.

2. Bucci, F.A., Jr.: Self-Assessment Protocol. Journal American Academy Dermatology 15:26A,

27A, 35A, 1986.

3. Bucci, F.A., Jr., Mesa, M., Schwartz, R.A., McNeil, G., Lambert, W.C.: Oral Lesions in

Lepromatous Leprosy. The Journal of Oral Medicine 42:4-6, 1987.

4. Bucci, F.A., Jr., Savia, P.V., Jr., Mauriello, J.A., Jr.: Herpes Zoster Ophthalmicus. American

Family Physician 35:121-128, 1987.

5. Bucci, F.A., Jr., Schwartz, R.A.: The Neurologic Complications of Herpes Zoster. American

Family Physician 37:185-192, 1988.

6. Bucci, F.A., Jr., Krohel, G.B.: Optic Nerve Swelling Secondary to the Obstructive Sleep Apnea

Syndrome. American Journal of Ophthalmology 105:428-430, 1988.

7. Bucci, F.A., Jr.: Oral Leprosy-Self Assessment Protocol, In: Problems in Dermatologic

Diagnosis and Management. W. Clark Lambert (Ed.), American Academy of Dermatology,

Evanston, Illinois, Pages 10-11, 14-15, 1988.

8. Bucci, F.A., Jr., Gabriels, C.F., Krohel, G.B.: Successful Treatment of Postherpetic Neuralgia

with Capsaicin. American Journal of Ophthalmology 106:758, 1988.

4

9. Bucci, F.A., Jr., Catalano, R.A., Simon, J.W.: Discordance of Accommodative Esotropia in

Monozygotic Twins. American Journal of Ophthalmology 107:84-85, 1989.

10. Bucci, F.A., Jr., Dimitsopulos, T.M., Krohel, G.B.: Branch Retinal Artery Occlusion Secondary

to Percutaneous Transluminal Coronary Angioplasty. British Journal of Ophthalmology 73:221-

222, 1989.

11. Beyer-Mears, A., Bucci, F.A., Jr., Delnal, M., Cruz, E.: Dietary Myo-Inositol Effect on Sugar

Cataractogensis. Pharmacology 39:59-68, 1989.

12. Bucci, F.A., Jr., Holland, E.J.: Flavobacterium Meningosepticum Keratitis Successfully Treated

with Topical Trimethoprim-Sulfamethoxazole. American Journal of Ophthalmology 111:116-

118, 1991.

13. Bucci, F.A., Jr., Lindstrom, R.L.: Total Pupillary Capture with Foldable Posterior Chamber

Intraocular Lens. Ophthalmic Surgery 22:414-415, 1991.

14. Bucci, F.A., Jr., Holland, E.J., and Lindstrom, R.L.: Corneal Autografts for External Suture

Knots in Transsclerally Sutured Lens Implants. American Journal of Ophthalmology 112:353-

354, 1991.

15. Bucci, F.A., Jr., Lopatynsky, M.O., Jenkins, P.L., Rickert, D.G., Gold, R.M.: The Acuvue

Disposable Contact Lens Versus the CSI Contact Lens in Patients with Giant Papillary

Conjunctivitis. American Journal of Ophthalmology 115:454-459, 1993.

16. Chan, C.C., Cogan, D.G., Bucci, F.A., Jr., et.al.: An Anterior Corneal Dystrophy with

Dyscollagenosis (Reis-Bucklers type?). Cornea 12:451-460, 1993.

17. Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: The Clinical Performance of the Surevue, Focus, and

CSI Daily Wear Lenses in Allergic and Normal Contact Lens Patients. CLAO Journal 20:159-

166, 1994.

18. Bucci, F.A., Jr., Lopatynsky, M.O., Zloty, P.C.: The Clinical Performance of the Acuvue,

NewVues, and SeeQuence Disposable Contact Lenses in Patients with Giant Papillary

Conjunctivitis. International Contact Lens Clinics 22:80-86, 1995.

19. Holland, E.J., Lee, R., Bucci, F.A., Jr., et. al.: Mottled Cyan Opacification of the Posterior

Cornea in Contact Lens Wearers. American Journal of Ophthalmology 119:620-626, 1995.

20. Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: The Clinical Performance of the Optima Toric

Contact Lens Versus the CSI Toric Contact Lens. CLAO Journal 23:43-48, 1997.

21. Bucci, F.A., Jr., Tanner, J.B., Moody, K.J.: Temporal Correlation of Tear IgE Levels with the

Onset of Symptoms in Patients Wearing Contact Lenses. ICLC Journal

22. Bucci, F.A., Jr., Moody, K.J., Tanner, J.B., Klyce, S.: Corneal Topographic Analysis of Ring-

Shaped Irregular Astigmatism Caused by Annular Tinted Contact Lenses. CLAO Journal

23:161-167, 1997.

5

23. Bucci, F.A., Jr., Myers, P.J., Tanner, J.B., Moody, K.J., Lopatynsky, M.O.: Clinical and

Overnight Corneal Swell Comparison of the 1-Day Acuvue Lens Versus the Medalist, Surevue,

Biomedics, and Acuvue Lenses. CLAO Journal 23:103-112, 1997.

24. Bucci, F.A., Jr., O’Brien, T.P., Evans, R.E., Myers, P.J.: A Prospective Comparison of Four

Methods of Pre-Phacoemulsification Antibiotic Treatment Using Ofloxacin and

Ciprofloxacin. Investigative Ophthalmology & Visual Science 41,4:S768, 2000.

25. Bucci, F.A., Jr.: Nutritional Amblyopia Resulting From Intra-Abdominal Surgery for

Obesity. (In Preparation)

26. Bucci, F.A., Jr.: An In Vivo Study Comparing the Ocular Absorption of Levofloxacin and

Ciprofloxacin Prior to Phacoemulsification. American Journal of Ophthalmology 137:308-312,

2004.

27. Bucci, F.A., Jr.: Consultation Section. Cataract Surgical Problem. Consultation on

Management of Case. Journal of Cataract & Refractive Surgery 31,12:2247-2253, 2005.

28. Bucci, F.A., Jr., Waterbury, L., Amico, L.M.: Prostaglandin PGE2 Inhibition and Aqueous

Concentration of Ketorolac 0.4% (Acular LS) and Nepafenac 0.1% (Nevanac) in Patients

Undergoing Phacoemulsification. American Journal of Ophthalmology, 144:147-147, 2007

29. Bucci, F.A., Jr., “In Vivo Pharmacokinetics and In Vitro Pharmacodynamics of

Nepafenac, Amfenac, Ketorolac, and Bromfenac”. Journal of Cataract and Refractive

Surgery, May 2008.

30. Bucci, F.A., Jr.: Comparing Ketorolac 0.4% and Bromfenac 0.09% at Trough Dosing:

Aqueous Drug Absorption and PGE2 Levels, Journal of Cataract & Refractive Surgery,

August 2008

31. Bucci, F.A., Jr.: Comparing Ketorolac 0.4% and Bromfenac 0.09% at Trough Dosing:

Aqueous Drug Absorption and PGE2 Levels Aqueous PGE2 at Trough NSAID Levels,

Advances in Therapy, March 2009

32. Bucci, F.A., Jr.: Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and

Bromfenac Levels After 2 Days Dosing, Advances in Therapy, May 2009

33. Bucci , F. A., Jr.: “A randomized comparison of to-aqueous penetration of ketorolac

0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing

phacoemulsification, Current Medical Research and Opinion, November 2011.

34. Bucci, F.A., Jr.: “Prostaglandin E2 Inhibition of Ketorolac 0.45%, Bromfenac 0.09%,

and Nepafenac 0.1% in Patients Undergoing Phacoemulsification, Advances in Therapy,

November 2011.

35. Bucci, F.A., Jr., Antibacterial Efficacy of Prophylactic besifloxacin 0.6% and

moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, Clinical Ophthalmology,

May 2015.

6

36. Bucci, F.A., Jr., Pharmacokinetics and Aqueous Humor Penetration of levofloxacin 1.5%

and moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, Clinical Ophthalmology,

May 2016.

37. Bucci, F.A., Jr., The Effect of Oral Re-Esterified Omega-3 Nutrional Supplementation on Dry

Eyes, Cornea, In press.

Book Chapters

1. Bucci, F.A., Jr.: Mastering Refractive IOLs – The Art and Science, Managing Patient

Expectations, New Jersey: Slack, Inc., 2008: 360-362.

2. Bucci, F.A., Jr.: Mastering Refractive IOLs – The Art and Science, Multifocal IOL in

One Eye, New Jersey: Slack, Inc., 2008: 454-455.

3. Bucci, FA., Jr.: Mastering Refractive IOLs – The Art and Science, Mini-RK:

Indications and Technique, New Jersey: Slack, Inc., 2008: 786-788.

4. Bucci, FA., Jr.: Premium Cataract Surgery: A Step-by-Step Guide, Enhancements with

Micro-Radial Keratotomy/Astigmatic Keratotomy, Slack, Inc., 2012.

5. Bucci, FA., Jr.: Premium Cataract Surgery: A Step-by-Step Guide, Enhancements with

Micro-Radial Keratotomy/Astigmatic Keratotomy, Slack, Inc., 2015.

Major Presentations:

1. “Characterization of Mycobacterial Plasmid and Chromosomal DNA.”

Presented at the 14th Annual New Jersey Medical School Summer Research Symposium,

Newark, New Jersey, Feb. 22, 1982

2. “Myo-Inositol Diminution of Diabetic Cataracts.”

Presented at the Annual Spring Meeting of the Association for Research in Vision and

Ophthalmology (ARVO), Sarasota, FL, May 7, 1985

3. “Papilledema and Obstructive Sleep Apnea.”

Presented at the 9th Annual Albany Ophthalmology Update Albany, New York, May 19,

1987

4. “The Deposit Resistant Hydrocurve Elite Soft Contact Lens and Giant Papillary Conjunctivitis –

A Preliminary Report.”

Presented at the 10th Annual Albany Ophthalmology Update, Albany, New York, June 18, 1988

5. “The Deposit Resistant Hydrocurve Elite Soft Contact Lens and Giant Papillary

Conjunctivitis – A Final Report.”

Poster Presentation at the Annual Spring Meeting of the Association for Research in

Vision and Ophthalmology (ARVO), Sarasota, FL, May 3, 1989

6. “The Acuvue Disposable Contact Lens and Giant Papillary Conjunctivitis - A

7

Preliminary Report.”

Presented at the 11th Annual Albany Ophthalmology Update, Albany, New York, June 3,

1989

7. “The Acuvue Disposable Contact Lens Versus the CSI Lens in Giant Papillary Conjunctivitis – A

Final Report.”

Poster Presentation at the Annual Meeting of the Contact Lens Association of

Ophthalmology (CLAO), Las Vegas, Nevada, January 11, 1990 (Awarded Best Scientific

Poster)

8. “The Effect of Intraincisional Thrombin on the Rate of Post-Operative Hyphema in

Cataract Surgery.”

Presented at the Annual Meeting of the American Society of Cataract and Refractive

Surgery (ASCRS), Los Angeles, CA, March 6, 1990

9. “Post-Operative Corneal Swelling in Cataract Patients Using Collagen Shields As a

Surgical Adjunct.”

Presented at the Annual Meeting of the American Society of Cataract and Refractive

Surgery (ASCRS), Los Angeles, CA, March 6, 1990

10. “Giant Papillary Conjunctivitis.”

Presented to the Minnesota Ophthalmological Society (M.O.S.), Minneapolis, MN, June 4,

1990

11. “Giant Papillary Conjunctivitis and Soft Contact Lenses.”

Presented at CIBA Vision as a Private Consultant, Atlanta, Georgia, August 9, 1990

12. “Refractive Surgery Update – Four Incision Radial Keratotomy and the Excimer Laser.”

Presented to the Northwest Ohio Ophthalmological Society (NOOS), Toledo, OH, March

10, 1991

13. “The Surgical Correction of Myopia.”

Presented at the Multidisciplinary Conference of Flower Memorial Hospital, Sylvania, OH, June

11, 1991

14. “Update in Refractive Surgery and the Treatment of Giant Papillary Conjunctivitis.”

Presented at the Annual Meeting of the Northeast Pennsylvania Optometry Society, Scranton,

PA, May 8, 1992

15. “Corneal Transplantation and Refractive Surgery Updates.”

Presented at the Tenth Annual Ophthalmic Assistant Conference of The Pugliese Eye Specialists,

Nanticoke, PA, October 10, 1992

16. “The Temporal Correlation of Tear IgE and the Onset of Symptoms in Contact Lens

Patients.”

Presented at the Annual Meeting of the Contact Lens Association of Ophthalmology (CLAO),

Las Vegas, NV, January, 1993

17. “The Clinical Performance of the Surevue, Focus, and CSI Daily Wear Lenses in Allergic and

Normal Contact Lens Patients.”

8

Poster presentation at the Annual Meeting of the Contact Lens Association of Ophthalmology

(CLAO), Las Vegas, NV, January, 1994 (Awarded Best Scientific Poster)

18. “Corneal Topographic Analysis of Ring-Shaped Irregular Astigmatism Caused by

Annular Tinted Contact Lenses.”

Poster presentation at the Annual Meeting of the Contact Lens Association of Ophthalmology

(CLAO), Las Vegas, NV, January, 1995 (Awarded Best Scientific Poster)

19. “The Clinical Performance of the Optima Toric Contact Lens Versus the CSI Toric

Contact Lens.”



20. “Management of Eightball Hyphema, Iatrogenic Aniridia, and Traumatic Cataract

Following Severe Blunt Trauma in a Patient with Previous Mini-RK/AK.”

Presented at the International Society of Refractive Surgery (ISRS), Atlanta GA, October, 1995

21. “Case Studies in Refractive and Cataract Surgery.”

Presented at the Orange County Ophthalmological Society Meeting, Irvine, CA, December, 1995

22. “Clinical and Overnight Corneal Swell Comparison of the 1-Day Acuvue Lens Versus the

Medalist, Surevue, Biomedics, and Acuvue Lenses.”


Las Vegas, NV, February, 1996

23. “Update in Refractive Surgery.”

Presented at the Central Pennsylvania Ophthalmology Society Meeting, Camp Hill, PA,

March 7, 1996

24. “Advances in Refractive Surgery.”

Presented at the Lehigh Valley Ophthalmic Society Meeting, Bethlehem, PA, March 12, 1996

25. “Does Perioperative Topical Marcaine Reduce Symptoms Following Radial Keratotomy?

Presented at Mid-Summer Meeting of the International Society of Refractive Surgery (ISRS),

Minneapolis, MN, July, 1996

26. “Acular Versus Voltaren for the Management of Post-Operative Symptoms Following Radial

Keratotomy.”

Presented at Mid-Summer Meeting of the International Society of Refractive Surgery

(ISRS), Minneapolis, MN, July, 1996

27. “Overnight Corneal Swell Response of the Protek Bandage Contact Lens Compared to the 1-

Day Acuvue, Acuvue, and Proclear Lenses.”

Presented at Mid-Summer Meeting of the International Society of Refractive Surgery (ISRS),

Minneapolis, MN, July, 1996

28. “On-Axis 2-Incision Mini-RK: An Effective Treatment for Primary and Residual Low

Myopic Astigmastism.”

Presented at the Pre-Academy Meeting of the International Society of Refractive Surgery

(ISRS), Chicago, IL, November, 1996

9

29. “The Protek Bandage Contact Lens – Prospective Evaluations of Post-RK Symptom

Management and Overnight Corneal Swell Analysis.”

Presented at the Contact Lens Association of Ophthalmology (CLAO), Las Vegas, NV, J

January, 1997

30. “Comparison of Post-Phacoemulsification IOP in Patients Treated with Timoptic-XE,

Iopidine, Trusopt, and Intracameral Carbastat.”

Presented at Royal Hawaiian Eye, Maui, HI, January, 1997

31. “Acular Versus Voltaren for the Management of Post-Operative Symptoms Following

Radial Keratotomy.”


32. “Control of Intraocular Pressure Following YAG Laser – Xalatan vs Alphagan.”


33. “A Clinical Comparison of the Acuvue Contact Lens vs the Precision UV Contact Lens.”



34. “Post-Op Control of Intraocular Pressure Following Phacoemulsification.”

Presented at Associazione Italiana di Facoemulsificazione, Rome, Italy, May, 1998

35. “The Role of Non-Steroidal Inflammatory Drops in Laser Vision Correction.”

Presented at the 7th Annual Ocular Surgery News Symposium, New York, NY, October, 1998

36. “Control of Post-Op Symptoms Following LASIK – Voltaren vs Acular PF.”

Presented at Royal Hawaiian Eye, Kona, HI, January, 1999

37. “A Clinical Comparison of the Precision UV Contact Lens vs the Acuvue Contact Lens

with the Orientation Logo and UV Blocker.”



38. “Post-Operative Symptom Profiles – PRK vs LASIK.”

Presented at Wills Eye Hospital Future Focus Program, Philadelphia, PA, January, 1999

39. “Control of Intraocular Pressure Following YAG Laser Capsulotomy – Iopidine 0.5% vs

Alphagan 0.2%.”

Presented at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium,

Seattle, WA, April, 1999

40. “Comparison of Acular PF and Voltaren vs Placebo in the Control of Post-Op Symptoms

Following LASIK.”



41. “Quantitative Analysis of Post-Operative Symptoms – PRK vs LASIK.”

10



42. “Peri-Operative Medications for Maximizing Patient Satisfaction in LASIK”

Presented at the New York State Ophthalmological Society Meeting, New York, NY, September,

1999

43. “NSAIDs and LASIK – What is the Optimum Dose?”

Presented at the 8th Annual Ocular Surgery News Symposium, New York, NY, October, 1999

44. “Topical Non-Steroidals and LASIK – What is the Optimum Postop Dose?”


(ISRS), Orlando, Fl, October 1999.

45. “A Prospective Comparison of Four Methods of Pre-Phacoemulsification Antibiotic Treatment

Using Ofloxacin and Ciprofloxacin.”


46. “The Optimum Use of NSAIDs with LASIK: A Review of Four Prospective Studies.”



using Ofloxacin and Ciprofloxacin.”

Poster presentation at 2000 Wills Eye Hospital Annual Conference, Philadelphia, PA, March

2000

48. “Diclofenac Sodium Ophthalmic Solution Versus Voltaren for the Control of Postoperative

Inflammation Following Phacoemulsification.”

Presented at 2000 Wills Eye Hospital Annual Conference, Philadelphia, PA, March, 2000



Poster presentation at Association for Research in Vision and Ophthalmology (ARVO) 2000

Annual Meeting, Fort Lauderdale, FL, April, 2000

50. “Diclofenac Sodium Ophthalmic Solution Versus Voltaren for the Control of Postoperative

Inflammation Following Phacoemulsification.”


Boston, MA, May, 2000



Poster presentation at the American Society of Cataract and Refractive Surgery (ASCRS)

Symposium, Boston, MA, May 2000

52. “Rehabilitation of Progressive Hyperopia, Astigmatism and Iatrogenic Aniridia with H LASIK

and Astigmatic Keratotomy.”

Poster presentation at the Pre-Academy Meeting of the International Society of Refractive

Surgery (ISRS), Dallas, TX, October 2000

11

53. Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for

Myopic LASIK.”


(ISRS), Dallas, TX, October, 2000

54. “Prospective Evaluations of Celluvisc Versus GenTeal Gel, Refresh Versus GenTeal, and

Refresh Plus Versus TheraTears During the First Month Following LASIK.”


(ISRS), Dallas, TX, October, 2000

55. “Optimum Control of Post Phaco Inflammation – Steroids, NSAIDs or Both: The Final Answer.”

Presented at Royal Hawaiian Eye, Koloa, Kauai HI, January, 2001.

56. “The LASIK Dry Eye: Presentation, Pathophysiology and Treatment.”

Presented at Royal Hawaiian Eye, Koloa, Kauai HI, January, 2001



Poster presentation at Wills Eye Hospital 2001 Annual Conference, Philadelphia, PA, March,

2001

58. “Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for

Myopic LASIK.”

Presented at Wills Eye Hospital 2001 Annual Conference, Philadelphia, PA, March, 2001

59. “Do Silicone Punctal Plugs Impact Tear Lactoferrin Levels Following LASIK?”


San Diego, CA, April, 2001

60. “Multivariant Regression Analysis of Flap Thickness Using the Hansatome Microkeratome for

Myopic LASIK.”


San Diego, CA, April, 2001




Symposium, San Diego, CA, April, 2001

62. Rehabilitation of Progressive Hyperopia, Astigmatism, Iatrogenic Aniridia, and Traumatic

Cataract with LASIK and AK Following Mini-RK and Severe Blunt Trauma.”







64. “Do Silicone Punctal Plugs Impact Tear Lactoferrin Levels Following LASIK?”

12



65. “The Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK?”


Surgery (ISRS), New Orleans, LA, November, 2001

66. “Myopic Refractive Lensectomy with the Array Multifocal Implant.”


Surgery (ISRS), New Orleans, LA, November, 2001

67. “Hyperopic Refractive Lensectomy with the Array Multifocal IOL.”


(ISRS), New Orleans, LA, November, 2001

68. “An Objective Comparison of Acular Versus Vexol to Control Inflammation Following

Phacoemulsification.”

Poster presentation at the 2001 Annual Meeting of the American Academy of Ophthalmology

(AAO), New Orleans, LA, November, 2001

69. “The Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK.”

Poster presentation at the 2001 Annual Meeting of the American Academy of Ophthalmology

(AAO), New Orleans, LA, November, 2001

70. “The LASIK Dry Eye Update: Tear Lactoferrin, Punctal Plugs, Hinge Position, HydroEye and

More.”

Presented at Hawaii 2002, Waikoloa, HI, January, 2002

71. An In Vivo Comparison of the Ocular Absorption of Levofloxacin versus Ciprofloxacin Prior to

Phacoemulsification.”


Annual Meeting, Fort Lauderdale, FL, May, 2002

72. Effect of Silicone Punctal Plugs on Tear Lactoferrin Following LASIK.”


Symposium, Philadelphia, PA, June, 2002

73. Myopic Refractive Lensectomy with the Array Multifocal Implant.”


Symposium, Philadelphia, PA, June, 2002

74. “Effect of HydroEye with Omega Fatty Acids on Tear Lactoferrin.”


Philadelphia, PA, June, 2002

75. “Hyperopic Refractive Lensectomy with the Array Multifocal IOL.”



76. “Dry Eye In LASIK: Preoperative Evaluation and Prevention.”

13



77. The Role of Fluoroquinolones in the Prevention of Endophthalmitis.”

Presented at the 11th Annual Ocular Surgery News Symposium, New York, NY, September,

2002

78. “Myopic Refractive Lensectomy with the Array Multifocal Implant.”


(ISRS), New Orleans, LA, October, 2002

79. “Prevention and Treatment of LASIK Dry Eye Patients.”


(ISRS), New Orleans, LA, October, 2002

80. “Refractive Lensectomy: The Array Multifocal Lens for the Correction of Myopia and

Hyperopia”.


81. “Myopic and Hyperopic Refractive Lensectomy with the Array Multifocal Implant.” Poster

presentation at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San

Francisco, CA, April, 2003

82. “The Ocular Absorption of Fluoroquinolone Antibiotics and the Prevention of Endophthalmitis.”

Poster presentation at American Society of Cataract and Refractive Surgery (ASCRS)

Symposium, San Francisco, CA, April, 2003

83. “The Effect of Continuous Preop and Postop Oral Omega Fatty Acids (HydroEye) on Tear

Lactoferrin in Bilateral LASIK Patients.”

Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium, San


84. “The Five Templates of LASIK Dry Eye – The Temporal Assessment and Treatment of Ocular

Surface Disease in LASIK Patients.”



85. “The Effect of Preop Lid Scrubs and Levofloxacin On Eyelid and Conjunctival Cultures Prior To




86. “The Ocular Absorption of Fluoroquinolones and the Prevention of Endophthalmitis.” Presented

at the 8th Annual International Joint Meeting of SOI, OSN, AICCER and ISRS, Florence

Symposium 2003, Florence, Italy, May, 2003

87. “A System for the Diagnosis and Treatment of LASIK Dry Eye.”

Presented at the 8th Annual International Joint Meeting of SOI, OSN, AICCER and ISRS,

Florence Symposium 2003, Florence, Italy, May, 2003

14

88. “Myopic And Hyperopic Refractive Lensectomy with the Array Multifocal Implant.”

Poster presentation at the European Society of Cataract and Refractive Surgeons (ESCRS)

Conference, Munich, Germany, September, 2003

89. “The Effect of Preop Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior to



Conference, Munich, Germany, September, 2003

90. “Refractive Lensectomy with the Array Multifocal Implant in Myopes and Hyperopes.”


(ISRS), Anaheim, CA, November, 2003

91. “Effect of Preop Lid Scrubs and Fluoroquinolones on Eyelid and Conjunctival Cultures Prior to


Presented at The Surgeon’s Fluoroquinolone Symposium, American Academy of

Ophthalmology (AAO), Anaheim, CA, November, 2003

92. “Effect of Preop Lid Scrubs and Fluoroquinolones on Eyelid and Conjunctival Cultures Prior to


Presented at Royal Hawaiian Eye, Kauai, HI, January, 2004

93. “Long-Term Results of Hyperopic & Myopic Lensectomy with the Array Multifocal Implant.”

Presented at Royal Hawaiian Eye, Kauai, HI, January, 2004

94. “A Comparison of Immediate Postop Aqueous Cultures in Phaco Patients Receiving

Gatifloxacin and Moxifloxacin Preoperatively.”



95. “A Comparison of Conjunctival and Eyelid Cultures in Phaco Patients Receiving Gatifloxacin

and Moxifloxacin Preoperatively.”



96. “Effect of Preoperative Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior

to Cataract Surgery.”


Symposium, San Diego, CA, May, 2004

97. “Refractive Lensectomy with the Array Multifocal Implant in Myopes and Hyperopes.”


Symposium, San Diego, CA, May, 2004

98. “Aqueous, Eyelid and Conjunctival Cultures in Phacoemulsification Using Zymar and Vigamox

Preoperatively .”


Diego, CA, May, 2004

15

99. “Effect of Preoperative Lid Scrubs and Levofloxacin on Eyelid and Conjunctival Cultures Prior

to Cataract Surgery.”

Presented at the 9th Annual International Joint Meeting of OSN, AICCER and ISRS, Italian

Society of Ophthalmology Meeting 2004, Naples, Italy, May, 2004

100. “Refractive Lensectomy with the Array Multifocal Implant for Myopes and Hyperopes.”

Presented at the 9th Annual International Joint Meeting of OSN, AICCER and ISRS, Italian

Society of Ophthalmology Meeting 2004, Naples, Italy, May, 2004

101. “Multivariant Regression Analysis of Flap Thickness Using the Amadeus Microkeratome for

Myopic LASIK.”


Conference, Paris, France, September 2004

102. “Long-Term Follow-Up of Refractive Lensectomy With the Array Multifocal Implant in Myopes

and Hyperopes.”


Conference, Paris, France, September 2004

103. “Acular LS Vs Acular in the Control of Inflammation Following Phacoemulsification.”


104. “Multivariant Regression Analysis of Flap Thickness Using the Amadeus Microkeratome for

Myopic LASIK .”


Symposium, Washington, DC, April 2005

105. “Acular, Acular LS, and Voltaren After Phacoemulsification as Mono Therapy and Combined

with Pred Forte .”

Presented at American Society of Cataract and Refractive Surgery (ASCRS) Symposium,

Washington, DC, April, 2005

106. “Comparison of Ketorolac 0.5%, Ketorolac and Diclofenac 0.1% Combined with

Prednisolone 1% on Aqueous Flare Following Cataract Surgery.”



107. “Prophylactic Strategies for the Prevention of Endophthalmitis.”

Presented at the 10th Annual International Joint Symposium of OSN and AICCER, Italian

Society of Ophthalmology, Florence, Italy, May, 2005

108. “Strategies for the Prevention and Treatment of LASIK Dry Eye.”

Presented at the 10th Annual International Joint Symposium of OSN and AICCER, Italian

Society of Ophthalmology, Florence, Italy, May, 2005

109. “Multivariant Regression Analysis of the Amadeus II Microkeratome Flap Thickness and a

Comparison of One Blade Vs. Two Blade Bilateral LASIK.”


Conference, Lisbon, Portugal, September 2005

16

110. “Intermediate Near Visual Function in Bilateral Multifocal Cataract and Lensectomy Patients

Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”


Conference, Lisbon, Portugal, September 2005

111. “Combining IOLs: Early Results.”

Presented at 2nd Annual Refractive IOL Symposium, Las Vegas, NV, December, 2005

112. “Multifocal IOLs ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”


113. “NSAID Update Acular LS vs. Nevanac.”

Presented at Johns Hopkins 28th Annual Current Concepts in Ophthalmology-P.R., San Juan,

Puerto Rico, February, 2006

114. “Multifocal IOLs ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”

Presented at Johns Hopkins 28th Annual Current Concepts in Ophthalmology-P.R., San Juan

Puerto Rico, February, 2006


Comparison of One Blade vs. Two Blade Bilateral LASIK.”


Francisco, CA, March, 2006

116. “Multifocal IOLs: ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”


Francisco, CA, March, 2006

117. “Intermediate and Near Visual Function in Bilateral Multifocal Cataract and Lensectomy

Patients Receiving ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”



118. “Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.4% vs. Nepafenac 0.1% In

Patients Undergoing Phacoemulsification.”



119. “A Comparison of Postoperative Inflammation (Flare) Following Routine Phacoemulsification

When Using Ketorolac Tromethamine 0.4% vs. Nepafenac 0.1%.”




Presented at the 13th Annual Meeting of the Canadian Society of Cataract Refractive Surgery,

Montreal, Canada, April, 2006



17

Presented at the 13th Annual Meeting of the Canadian Society of Cataract Refractive Surgery,

Montreal, Canada, April, 2006


Presented at the 11th Annual International Joint Meeting of OSN, SOI, AICCER, and

ISRS/AAO, Rome, Italy, May, 2006-

123. “Combining the ReZoom and ReSTOR Multifocal IOLs for Achieving Maximum

Patient Outcomes.”

Presented at the 11th Annual International Joint Meeting of OSN, SOI, AICCER, and

ISRS/AAO, Rome, Italy, May, 2006

124. “Presbyopia-Correcting IOLs: Maximizing Patient Satisfaction and Spectacle Independence.”

Lecture at the Summer ASCRS Meeting, Boston MA, August, 2006


Comparison of One Blade vs. 2 Blade Bilateral LASIK.”

Presented at the XXIV Congress of ESCRS, London, September, 2006


Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN, October, 2006

127. “NSAIDS: Optimizing Surgical Outcomes.”

Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN. October, 2006

128. “Multifocal IOLs: Current Perspective.”

Presented at Phillips Eye Institute’s 2006 Cataract Conference, Minneapolis, MN, October, 2006

129. “Intermediate and Near Visual Function in Bilateral Multifocal Patients Receiving

ReZoom/ReSTOR vs. ReSTOR/ReSTOR.”

Presented at American Academy of Ophthalmology (AAO), Las Vegas, NV, November , 2006

130. “Spotlight on Management of Presbyopia.”

Presented at American Academy of Ophthalmology (AAO), Las Vegas, NV,

November , 2006



Presented at the Refractive IOL Symposium, Scottsdale, AZ, December, 2006

132. “ReZoom/ReSTOR vs. ReSTOR/ReSTOR: Patient Satisfaction, Visual Outcomes and Spectacle

Independence.”

Presented at Royal Hawaiian Eye, Kauai, Hawaii, January, 2007

133. “The Use of NSAIDs with Cataract & Lensectomy Surgery.”

Presented at the Ocular Drug & Surgical Therapy Update, Dana Point, CA,

February, 2007

134. “Visual Function in Bilateral Lensectomy and Cataract Patients Receiving ReZoom/ReSTOR vs.

ReSTOR/ReSTOR:Long Term Follow-Up.”

18



135. “Micro RK/AK to Treat Residual Refractive Errors After Multifocal IOLs vs. Laser Vision

Correction and LRI.”



136. “Comparison of Aqueous Absorption and PGE2 Inhibition with Ketorolac 0.4%, Nepanenec

0.1% and Bromfenac 0.9% in Cataract Patients Treated Preoperatively.”


Diego, CA, April, 2007 (Awarded Best Paper of Session)

137. “Aqueous Penetration of Ketorolac 0.4% Compared with Bromfenac 0.9% in Cataract Patients:

Peak and Trough Drug Concentration.”



138. “Vaseline Vision Dysphotopsia and Explantation Rates of the ReSTOR and ReZoom Multifocal

Implants.”



139. “Bilateral Multifocal Cataract and Lensectomy Patients Receiving ReZoom/ReSTOR vs.

ReSTOR/ReSTOR-Long Term Follow-Up.”



140. “Vaseline Vision Dysphotopsia and Explantation Rates of the ReSTOR and ReZoom Multifocal

Implants.”

Presented at the 12th Annual International Joint Meeting of OSN, SOI, AICCER at the Italian

Society of Ophthalmology (SOI) Congress, Rome, Italy, May, 2007 - Keynote Address

141. “Near and Intermediate Visual Outcomes in Diffractive/Diffractive vs. Refractive/Diffractive

Multifocal Lens Combination.”

Presented at the 12th Annual International Joint Meeting of OSN, SOI, AICCER at the Italian

Society of Ophthalmology (SOI) Congress, Rome, Italy, May, 2007

142. “The Dynamics of the Preop Presbyopic Consultation.”

Presented at the Eye Center Conference, Columbus, OH, September 2007

143. “Mixing Multifocal IOLs to Achieve Maximum Patient Satisfaction.”


144. “Treatment Strategies for Residual Refractive Errors and the Results of Unilateral

Multifocals.”


145. “Vaseline Vision Dysphotopsia” and Explantation of the ReSTOR and ReZoom Multifocal

Implants.”

19

Presented at the XXV Congress of ESCRS, Stockholm, Sweden, September 200

146. “Micro RK/AK” for Correcting Residual Refractive Errors Following Presbyopic IOLs.”

Presented at the XXV Congress of ESCRS, Stockholm, Sweden, September 2007

147. “Unilateral Implantation of the ReZoom and ReSTOR Multifocal IOLs” Presented at the

American Academy of Ophthalmology, New Orleans, LA, November 2007

148. “ “Micro RK/AK” for Correcting Residual Refractive Errors Following Presbyopic

IOLs”, Poster Presentation American Academy of Ophthalmology, New Orleans, LA,

November 2007

149. “Achieving Success with Multifocal IOLs: Clinical Results and Practical Pearls”,

Course Senior Instructor, American Academy of Ophthalmology, New Orleans, LA,

November 2007

150. “Maximizing Patient Satisfaction with Presbyopia Correcting IOLs”, Presented at Sunday

Breakfast Seminar, Royal Hawaiian Eye, Waikoloa, HA, January 2008

151. “Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Royal Hawaiian

Eye, Waikoloa, HA, January 2008

152. “First 100 Days”, Hawaiian Eye – Subspecialty Saturday, Royal Hawaiian Eye,

Waikoloa, HA, January 2008

153. “Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Nursing and

Allied Health Program, Royal Hawaiian Eye, Waikoloa, HA, January 2008

154. “Staying in Step with Innovation”, Course presented at SECO International,

February 2008

155. “When to Explant”, Presentation at 2008 Winter Cataract Refractive Invitational Summit,

Telluride, CO, February 2008

156. “Tailoring the Preoperative Interview for Presbyopic IOL Candidates”, Presentation at

Advanced Medical Optics Bringing You the Future Meeting, Mont Tremblant, Canada,

February 2008

157. “Multifocal IOL Selection for Achieving Patient Satisfaction”, Presentation at


February 2008

158. “Vaseline Vision Dysphotopsia/Treating Residual Refractive Error”, Presentation at


February 2008

159 “The TECNIS Multifocal”, Presentation at the Aspen Invitational Refractive

Symposium, Aspen, CO, March 2008

160. “Achieving High Levels of Patient Satisfaction with Multifocal and Accommodating

IOLS”, Presented at Ground Rounds Downstate Medical Center, New York,

20

March 2008

161. “Conjunctival Goblet Cell Density Following Sequential Therapy with Artificial Tear

and Cyclosporine 0.05%”, Poster presentation at American Society of Cataract and

Refractive Surgery (ASCRS) Symposium, Chicago, IL, April 2008

162. “Achieving High Levels of Patient Satisfaction with Multifocal and Accommodating

IOLs”, Presented as course at American Society of Cataract and Refractive Surgery

(ASCRS) Symposium, Chicago, IL, April 2008

163. “The 10 P’s of Correcting Presbyopia: Pearls for Maximizing Patient Satisfaction”

Presented at The IV International Congress of Refractive Surgery, Cataract and

Glaucoma, Lima, Peru, April 2008

164. “Optimizing the Use of PCIOLs: Unilateral, Bilateral, Mix & Match”

Presented The IV International Congress of Refractive Surgery, Cataract and Glaucoma,

Lima, Peru, April 2008

165. “A Comparison of Silcone Hydrogel vs. Specialty Dry Eye Contact Lenses in Previous

Dry Eye Patients with and without Restasis”, Poster presentation at Association for

Research in Vision and Ophthalmology (ARVO), 2008 Annual Meeting, Fort

Lauderdale, FL, May 2008

166. “Visual Outcomes and Patient Satisfaction of Cataract and Refractive Lensectomy

Patients Receiving Bilateral ReZoom Multifocal Implants”, Poster presentation at

Association for Research in Vision and Ophthalmology (ARVO), 2008 Annual

Meeting, Fort Lauderdale, FL, May 2008

167. “NSAIDs in Today’s Ophthalmology Climate”, Allergan External Disease Market

Guidance Program, Boston, MA- May 2008

168. “Endophthalmitis Prevention”, Allergan External Disease Market


169. “Optimizing Outcomes in Refractive Surgery”, Allergan External Disease Market


170. “Alternatives for Correcting Residual Refractive Errors: Laser & Incisional”,

New York SOURCE Symposium, New York, NY – June 2008

171. “Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and

Bromfenac Levels After 2 Days Dosing” Presented at: ARVO Summer Eye

Research Conference (SERC), Monterey, CA – July 2008

172. “Update on the Tecnis Multifocal IOL”, Summer Refractive Invitational Summit 2008,

Aspen, CO – July 2008

173. “Unilateral Implantation of the ReZoom & ReSTOR Multifocal IOLs”,

Presented at the XXVI Congress of ESCRS, Berlin, Germany – September 2008

21

174. “Tailoring the Presbyopic Consultation & Strategied for Achieving an Effective

Preoperative Interview”, Refractive IOL Symposium, Las Vegas, NV – September 2008

175. “NSAIDs & Anti-Infectives Panel”, Corneal Health Roundtable, Ocular Surgery News

Symposium, New York, NY – October 2008

176. “Achieving Success with Presbyopic Correcting IOLs”, The Montreal Eye Clinic’s 9th

Optometric Symposium, Montreal, Quebec – October 2008

177. “Implantation of Presbyopic Correcting IOLs Post Keratorefractive Surgery in Cataract

and Lensectomy Patients”, American Academy of Ophthalmology, Atlanta, GA –

October 2008

178. “Roadmap to Success with Multifocal IOLs”, Meeting Instruction Course, American

Academy of Ophthalmology, Atlanta, GA – October 2008

179. “10 Pearls to Improve Outcomes with Advance Multifocal IOL Implantation”, American

Academy of Ophthalmology, Atlanta, GA – October 2008

180. “Surgical Treatment of Presbyopia”, Focal Points: Clinical Modules for

Ophthalmologists, American Academy of Ophthalmology, Atlanta, GA – October 2008

181. “Optimizing the Ocular Surface with Natural Triglyceride Omega 3 Fish Oils”,

Royal Hawaiian Eye, Maui, HA – January 2009

182. “Optimizing the Ocular Surface with Natural Triglyceride Omega 3 Fish Oils”,

Nursing and Allied Health Program, Royal Hawaiian Eye , Maui, HA – January 2009

183. Allergan Dry Eye Advisory Summit, Miami Beach, FL – February 2009

184. “Unilateral Implantation of Presbyopic Correcting IOLs: Comparison of ReZoom,

ReSTOR, Cyrstalens 5.0, and Crystalens HD”, Poster presentation at American

Society of Cataract and Refractive Surgery (ASCRS) Symposium, 2009 Annual

Meeting, San Francisco - April 2009

185. “Maximizing Patient Satisfaction with Presbyopic Correcting IOLs”, Course Instructor

JCAHPO/ASCRS Technicians & Nurses Program, ASCRS 2009 Annual Meeting,

San Francisco, CA - April 2009

186. “Ten Pearls to Improve Outcomes with Advanced Multifocal IOL Implantation”,

Co-Instructor Course Instructor, ASCRS 2009 Annual Meeting, San Francisco, CA -

April 2009

187. “Bioavailability of Ethyl Ester Versus Triglyceride Omerga-3 Fatty Acids”,

Presented at American Society of Cataract and Refractive Surgery (ASCRS)

Symposium, San Francisco, CA - April 2009

188. “Pharmacokinetics and Aqueous Humor Penetration”, Presented at Vistakon

Pharmaceuticals ASCRS Breakfast Symposia, ASCRS, San Francisco, CA - April 2009

22

189. “The Pharmacokinetics and Aqueous Humor Penetration of Levofloxacin 1.5% and

Moxifloxacin 0.5% in Patients Undergoing Cataract Surgery, ARVO, May 2009

190. “Achieving Clinical Success with the New TECNIS Multifocal”, Ocular Surgery News

New York, NY – September 2009

191. “Clinical Pearls & Update on Custom Matching and Staged Implantation”, Ocular

Surgery News New York, NY – September 2009

192. “Do YAG Capsulotomies in Eyes with a Crystalens Significantly Impact Spherical

Refraction and Near Visual Function?”, ISRS/AAO Refractive Surgery Subspecialty

Day, San Francisco, CA – October 2009

193. “A Novel Pharmacokinetic Study Comparing Corneal Penetration of Levofloxacin 1.5%

and Moxifloxacin 0.5%”, New Insights into Corneal Protection, American Academy of

Ophthalmology, San Francisco, CA – October 2009

194. “Clinical Pearls & Update on Custom Matching and Staged Implantation”, Co-Instructor,

Roadmap to Success with Presbyopic IOLs, American Academy of Ophthalmology,

San Francisco, CA – October 2009

195. “Tailoring the Presbyopic Consultation: Strategies for Achieving an Effective

Preoperative Interview”, Co-Instructor, American Academy of Ophthalmology,


196. “Clinical Pearls & Update on Custom Matching and Staged Implantation”, Co-Instructor

Presbyopia Correcting IOL’s: The Best Option, American Academy of Ophthalmology,


197. “Mixing and Matching Presbyopia-Correcting IOLs”, Online course for the American

Academy of Ophthalmology O.N.E. program, San Francisco, CA – October 2009

198. “Achieving Practice and Patient Success in the New Age of Multifocal Lenses”,

Moderator Roundtable, Philadelphia, PA – November 2009

199. “Achieving Practice and Patient Success in the New Age of Multifocal Lenses”,

Moderator Roundtable, New York, NY – November 2009

200. "Effect of Postoperative Atropine,YAG Capsulotomy, Spherical Aberration,

Defocus, and Pupil Size on Near Visual Performances of Models of Blended

Hinged Accommodating IOLS", Nursing and Allied Health Program, Royal Hawaiian

Eye , Koloa, HA – January 2010

201. "Effect of Postoperative Atropine,YAG Capsulotomy, Spherical Aberration,

Defocus, and Pupil Size on Near Visual Performances of Models of Blended

Hinged Accommodating IOLS", Royal Hawaiian Eye , Koloa, HA – January 2010

202. "The Pharmacokinetics and Aqueous Humor Penetration of Levofloxacin 1.5% and

Moxifloxacin 05% in Patients Undergoing Cataract Surgery", The 5th International

Conference on Ocular Infections, Palm Beach, FL - February, 2010

23

203. "Achieving Success with Presbyopic Correcting IOLs: Preoperative Counseling, IOL

Selection, and Treatment of Residual Refractive Error, Course Instructor, American

Society of Cataract and Refractive Surgery (ASCRS) Symposium, Boston, MA - April

2010

204. "Effect of Postoperative Atropine, YAG Capsulotomy, Spherical Aberration, Defocus, and

Pupil Size on Near Visual Performances of Two Models of Blended Aspheric Hinged

Accommodating IOLs, Presented at American Society of Cataract and Refractive Surgery

(ASCRS) Symposium, Boston, MA - April 2010

205. "Comparison of Staged Implantation Strategies with Multifocal and Accomodating IOLs

for Maximizing Patient Satisfaction, Presented at American Society of Cataract and

Refractive Surgery (ASCRS) Symposium, Boston, MA - April 2010

206. "Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.45%, Bromfenac 0.09%, and

Nepafenac 0.1% in Patients Undergoing Phacoemulsification", Poster presentation at

Association for Research in Vision and Ophthalmology (ARVO), 2010 Annual Meeting,

Fort Lauderdale, FL, May 2010

207. "Aqueous PGE2 Inhibition of Ketorolac Tromethamine 0.45%, Bromfenac 0.09%, and

Nepafenac 0.1% in Patients Undergoing Phacoemulsification, Poster presentation at


Fort Lauderdale, FL, May 2010

208. " Visual Performance and Patient Satisfaction When Mixing a TECNIS Multifocal

with a Crystalens", Presented at the XXVIII Congress of ESCRS, Paris, France –

September 2010

209. " Bilateral Visual Outcomes with the Combination of a Crystalens and TECNIS

Multifocal", E-Poster, ISRS/AAO Refractive Surgery Subspecialty Day, Chicago, IL

October 2010

210. "Visual Performance and Patient Satisfaction When Mixing a Diffractive Multifocal

IOL with an Accommodating IOL", Royal Hawaiian Eye , Maui, HA – January 2011

211. "Comparison of RBC Saturation withOmega-3 Oral Supplements", Electronic Poster,

Presented at American Society of Cataract and Refractive Surgery

(ASCRS) Symposium, San Diego, CA - March, 2011

212. " Ketorolac vs. Bromfenac: A Review of 7 Prospective Randomized Studies Comparing

PGE2 Inhibition and Aqueous Penetration", Electronic Poster Presented at American

Society of Cataract and Refractive Surgery (ASCRS) Symposium, San Diego, CA -

March, 2011

213. "A Comparison of Omega-3 RBC Saturation for Three Oral Supplements: Dry Eye

Omega Benefits vs. TheraTears Nutrition vs. Nature Made, Poster presentation at


Fort Lauderdale, FL, May 2011.

24

214. " A Comparison of the Bioavailability by Red Blood Cell Saturation of Re-esterified

Triglyceride Omega-3s vs. Ethyl Ester Omega-3s presented as an ePoster at the

American Academy of Ophthalmology, Orlando, FL, October 2011.

215. "The Art of Achieving Success With Presbyopic-Correcting Intraocular Implants: The

Consultation, the IOLs, and Correcting Residual Refractive Errors, Course Instructor,

American Academy of Ophthalmology, Orlando, FL, October 2011.

216. "Tailoring the Presbyopic Consultation: Strategies for Achieving an Effective

Preoperative Interview", Royal Hawaiian Eye , HA – January 2012.

217. "An Outcomes Comparison of Bilateral vs. Mix & Match: What I have learned after

implanting 2600 Presbyopic Correcting IOLs ", HA - January 2012.

218. "A Comparison of Bilateral Diffractive Multifocal to a Diffractive Multifocal Combined with a

Zonal-Refractive Multifocal IOL", American Society of Cataract and Refractive Surgery

(ASCRS) Symposium, Chicago 2012.

219. "A Comparison of the Bioavailability by RBC Saturation of Re-esterified Triglyceride

Omega-3s vs. Ethyl Ester Omega-3s", American Society of Cataract and Refractive

Surgery (ASCRS) Symposium, Chicago 2012.

220. "Visual Performance, Reading Speed, and Patient Satisfaction after Receiving Bilateral

Multifocal IOLs", American Society of Cataract and Refractive Surgery (ASCRS)

Symposium, San Francisco 2013.

221. " The Pharmacokinetics and Aqueous Humor Penetration of Besifloxacin 0.6% and

Moxifloxacin 0.5% in Patients Undergoing Cataract Surgery", Poster presentation at

Association for Research in Vision and Ophthalmology (ARVO), Annual Meeting,

Seattle 2013.

222. "A Comparison of Prophylactic Antibacterial Efficacy of Besifloxacin 0.6% versus

Moxifloxacin 0.5% at 1 hour and 3 days prior to Phacoemulsification", Poster presentation at


Seattle 2013.

223. “Multivariate Analysis of Overall Bilateral Satisfaction vs. Preoperative and Outcome Data

of Patients Receiving Diffractive Multifocal Implants”, Royal Hawaiian Eye , HA,

January 2014.


of Patients Receiving Diffractive Multifocal Implants”, Nursing and Allied Health Program,

Royal Hawaiian Eye , HA – January 2014.

225. “Antibacterial Susceptibility of Coagulase Negative Staph Before and After Prophylactic

Use of Besifloxacin and Moxifloxacin”, Poster presentation at Association for Research in

Vision and Ophthalmology Annual Meeting, Orlando (ARVO), 2014.

226. “Multivariate Regression Analysis of Overall Bilateral Patient Satisfaction in Patients

Receiving Bilateral TECNIS Multifocal Implants”, European Society of Cataract and

25

Refractive Surgeons Annual Meeting (ESCRS), London, 2014.

227. “Multivariate Analysis of Overall Bilateral Satisfaction vs Preoperative and Outcome Data

of Patients Receiving Diffractive Multifocal Implants”, Electronic poster presentation,

International Society of Refractive Surgery Annual Meeting (ISRS), Chicago 2014.


of Patients Receiving Diffractive Multifocal Implants”, Royal Hawaiian Eye, HA, January 2015.

229. “Effect of Oral Re-esterified Omega-3 Supplementation on Dry Eye Disease: Double-masked

Randomized, Multicenter, and Placebo-controlled Study”, Royal Hawaiian Eye, HA, January

2016.

230. “A Comparison of the Frequency of Use of the Malyugin Ring® With and Without Intracameral

Phenylephrine & Ketorolac 1%/0.3% Injection at the Time of Routine Cataract Surgery”, ARVO, Seattle,

WA, May 2, 2016.

231. “The Effect of Mesopic Pupil Size and IOL Centration on Overall Patient Satisfaction

with the TECNIS Multifocal IOL”, ASCRS, New Orleans, 2016.

232. “Achieving Success with Presbyopic Correcting IOLs: Pre op Counseling, IOL Selection, and

Treatment of Residual Refractive Error”, Course Instructor, ASCRS, New Orleans, 2016.

233. “A Comparison of the Frequency of use of the Malyugin Ring with and without Intracameral

Phenylephrine 1% and Ketorolac 0.3% at the Time of Routine Cataract Surgery”, Royal

Hawaiian Eye, HA, January, 2017.

Trade Periodical “Publications”

1. Bucci, F.A., Jr.: Roundtable Participant. “Maximizing Success in Refractive Surgery”.

Ocular Surgery News. June 1997.

2. Bucci, F.A., Jr.: Roundtable Participant. “Management of Ocular Inflammation:

Evaluating Current Treatment Options”. Ocular Surgery News. July 1997.

3. Bucci, F.A., Jr.: Roundtable Participant. “Opportunities and Techniques in Improving

Cataract Patient Outcomes”. Ocular Surgery News Supplement. May 1999.

4. Bucci, F.A., Jr.: Roundtable Participant. “Ocular Surface Rehabilitation”. CIBA

Vision Ophthalmics by The Willow Group, Inc. August 1999.

5. Bucci, F.A., Jr.: Roundtable Participant. “Use of NSAIDs in LASIK”. Ophthalmology

Times. February 2000.

6. Bucci, F.A., Jr.: Research Featured In: “One Drop of NSAID Immediately Following

LASIK is the Best Regimen”. Ocular Surgery News. April 2000.

7. Bucci, F.A., Jr.: Research Featured In: “One Drop of NSAID Helps Post-LASIK

Relief”. Ophthalmology Times. May 2000.

26

8. Bucci, F.A., Jr.: Research Featured In: “Surgeons Extrapolate the Best Prophylaxis Methods

from Studies”. Ocular Surgery News. July 2000.

9. Bucci, F.A., Jr.: Research Featured In: “Post Cataract Combination Therapy”. EyeWorld. May

2001.

10. Bucci, F.A., Jr.: Research Featured In: “Head Off Dry Eye Before Surgery - 10 Questions You

Must Ask Your LASIK Patients”. Optometric Management. May 2001.

11. Bucci, F.A., Jr.: Research Featured In: “Nonsteroidal Anti-Inflammatory Drugs: Options and

Applications in Ophthalmic Use”. Ocular Surgery News. May 2001.

12. Bucci, F.A., Jr.: Research Featured In: “Treat Dry Eye Aggressively with Non-Preserved Tears”.

Ocular Surgery News. September 2001.

13. Bucci, F.A., Jr.: Research Featured In: “A Review of the ASCRS NSAIDs Survey Results”.

EyeWorld. September 2001.

14. Bucci, F.A., Jr.: Research Featured In: “Plugs Benefit High-Risk Cases”. Ophthalmology Times.

August 2001.

15. Bucci, F.A., Jr.: Research Featured In: “Treat Dry Eye Aggressively with Non-Preserved Tears”.

Ocular Surgery News. August 2001.

16. Bucci, F.A., Jr.: Research Featured In: “Perioperative Prophylaxis – The Search for the

Surgeon’s Fluoroquinolone”. EyeWorld. November 2001.

17. Bucci, F.A., Jr.: Research Featured In: “Dry Eye Treatment Can Elevate Lactoferrin Levels in

Tears Prior to Refractive Surgery”. Ocular Surgery News. February 2002.

18. Bucci, F.A., Jr.: Research Featured In: “Update On Diagnosing Dry Eye”. Ophthalmology

Management. February 2002.

19. Bucci, F.A., Jr.: Research Featured In: “Post-LASIK Dry Eye Can Be Managed Effectively

Surgeons Say”. Ocular Surgery News Europe/Asia-Pacific Edition. March 2002.

20. Bucci, F.A., Jr.: Research Featured In: “At Issue Column-Management of LASIK Dry Eye”.

Ocular Surgery News. March 2002.

21. Bucci, F.A., Jr.: Roundtable Participant. “Use of NSAIDs in LASIK”. Ophthalmology Times.

April 2002.

22. Bucci, F.A., Jr.: Research Featured In: “Surgeon: Punctal Plugs Help Restore Tear Lactoferrin”.

Ocular Surgery News. April 2002.

23. Bucci, F.A., Jr.: “Astigmatism, High Myopia, and the Array”. Cataract & Refractive Surgery

Today. April 2002.

27

24. Bucci, F.A., Jr.: “Endophthalmitis Prophylaxis and the Corneal Penetration of Topical

Fluoroquinolones”. Cataract & Refractive Surgery Today. April 2002.

25. Bucci, F.A., Jr.: Research Featured In: “Complications of Refractive Surgery”. EyeWorld. July

2002.

26. Bucci, F.A., Jr.: Research Featured In: “Dealing with Dry Eye”. EyeWorld. June 2002.

27. Bucci, F.A., Jr.: Co-author of Monograph: “Ophthalmic Therapeutics: The Surgeon’s

Fluoroquinolone”. Ocular Surgery News. May 2002.

28. Bucci, F.A., Jr.: Co-author of Monograph: “Treating Ocular Surface Disease Through Medical

Therapy”. Ophthalmology Times. September 2002.

29. Bucci, F.A., Jr.: Research Featured In: “Lensectomy with Multifocal IOL Renders Impressive

Visual Results”. Ocular Surgery News. November 2002.

30. Bucci, F.A., Jr.: Research Featured In: “Preventing Postoperative Infection”. Cataract &

Refractive Surgery Today. November 2003.

31. Bucci, F.A., Jr.: Co-author of Monograph: “The Surgeon’s Fluoroquinolone: Letting the Science

Speak for Itself”. Ocular Surgery News. November 2003.

32. Bucci, F.A., Jr.: Research Featured In: “Omega Fatty Acid Supplements Useful Strategy Before

LASIK”. Ophthalmology Times. November 2003.

33. Bucci, F.A., Jr.: Research Featured In: “A Dry Eye Regimen for Cold Weather?”. EyeWorld.

November 2003.

34. Bucci, F.A., Jr.: Research Featured In: “Lid Scrubs Plus Levofloxacin a Potent Antimicrobial

Prophylaxis”. ESCRS Eurotimes. November 2003.

35. Bucci, F.A., Jr.: Research Featured In: “Comprehensive Dry Eye Treatments”. Cataract &

Refractive Surgery Today. January 2004.

36. Bucci, F.A., Jr.: Research Featured In: “Treating the Dry Eye: The Role of Artificial

Tears”. Refractive Eyecare For Ophthalmologists. June 2004.

37. Bucci, F.A., Jr.: Research Featured In: “NSAIDs Steroids, or Both for Cataract Surgery?”.

EyeWorld. August 2004.

38. Bucci, F.A., Jr.: Research Featured In: “Easing Surgical Recovery”. Ophthalmology

Management. September 2004.

39. Bucci, F.A., Jr.: Research Featured In: “Options to Consider for Bed Hydration”. EyeWorld.

September 2004.

40. Bucci, F.A., Jr.: Research Featured In: “Topical Antibiotic Prophylaxis”. Cataract & Refractive

Surgery Today. February 2005.

28

41. Bucci, F.A., Jr.: Roundtable Participant. “NSAID Uses in Cataract and Refractive Surgery”.

Supplement to Ophthalmology Times. February 2005.

42. Bucci, F.A., Jr.: Research Featured In: “A Strategy for Endophthalmitis Prophylaxis”. Refractive

Eyecare. November 2005.

43. Bucci, F.A., Jr.: Cataract Surgery Phaco Pearls Participant. “Achieving a Watertight Incision”.

Cataract & Refractive Surgery Today. January 2006.

44. Bucci, F.A., Jr.: Roundtable Participant. “Philosophy of Mixing IOLs for Presbyopia Correction

Spurs Debate”. Ocular Surgery News. January 2006.

45. Bucci, F.A., Jr.: Roundtable Participant. “LASIK Infection Prophylaxis: A Roundtable

Discussion”. Review of Ophthalmology. February 2006.

46. Bucci, F.A., Jr.: Featured In: “Highlights of ASCRS”. Ocular Surgery News. April 2006

47. Bucci, F.A., Jr.: Featured In: Mixing & Matching vs. Bilateral IOLs”. Refractive Surgery

Quarterly. 2006.

48. Bucci, F.A., Jr.: Featured In: “ASCRS Summer Refractive Congress Highlights New

Technologies”. Ocular Surgery News. September 2006.

49. Bucci, F.A., Jr.: Featured In: “Patient Selection, Preoperative Evaluation Critical for Success”.

Ocular Surgery News Supplement. October 2006.

50. Bucci, F.A., Jr.: Featured In: “Flap Thickness Formula Aids in Decision-Making”.

Ophthalmology Times. January 2007.

51. Bucci, F.A., Jr.: Research Featured In: “Mixing & Matching IOLs”. Cataract & Refractive

Surgery Today Supplement. February 2007.

52. Bucci, F.A., Jr.: Roundtable Participant. “IOL Options in 2007”. Cataract & Refractive Surgery

Today – Annual IOL Issue. February 2007.

53. Bucci, F.A., Jr.: Waxy Vision and Selected Multifocal IOL;

Managing Patient Expectations, Ocular Surgery News, March 2007

54. Bucci, F.A., Jr.: Research Featured In: “Studies Suggest Superiority of Ketorolac in Cataract

Surgery”. Special Section: ASCRS Cataract News – Ophthalmology Times July 2007.

55. Chu, Y.R., Bucci, F.A., Jr., McDonald II, J.E., et. al.: “Refractive Lens Exchange”. Cataract &

Refractive Surgery Today. August 2007.

56. Bucci, F.A., Jr.: Research Featured In: Endophthalmitis Should Not Overshadow Other Severe

Complications”. Ocular Surgery News. October 2007.

57. Bucci, F.A., Jr.: “Mastering Preoperative Interviews”. Cataract & Refractive Surgery Today.

November/December 2007.

29

58. Bucci, F.A., Jr.: “Roudtable Participant. “Attracting, Communicating, and Converting Patients to

Refractive IOLs”. Cataract & Refractive Surgery Today. November/December 2007.

59. Bucci, F.A., Jr.: “Mixing and Matching with the ReZoom Multifocal: Best of Both Worlds?”.

EyeWorld. May / June 2008.

60. Bucci, F.A., Jr.: A Multifocal with Mass Appeal: The Tecnis Multifocal IOL,

Cataract & Refractive Surgery Today, January 2009.

61. Bucci, F.A., Jr.: Natural Triglycerides Omega-3s Out Perform Ethyl Ester Omegas,

Optimizes Dry Eye Treatment and ARMD Prevention, Ocular Surgery News,

June 2009.

62. Bucci, F. A., Jr., Aqueous Prostaglandin E2 of Cataract Patients at Trough Ketorolac and

Bromfenac Levels After 2 days Dosing, Advances in Therapy, June 2009.

63. Bucci, F.A., Jr., Corneal Aqueous Penetration: Fluoroquinoline Pharmacokinetic Study

Findings, ASCRS EyeWorld, August 2009.

64. Bucci, F.A., Jr., Clinician's Corner, Focal Points, Clinical Modules for Ophthalmologists,

September, 2009.

65. Bucci, F.A., Jr., Building a Presbyopic IOL Practice, Practice Management, Special to

Ophthalmology Times, October 2009.

66. Bucci, F.A., Jr., Update on Mastering Refractive IOLs: Tools of the Trade, Premier

Surgeon, July/August 2010.

67. Bucci, F.A., Jr., Methicillin Resistance of Staphylococcus Species Among Health Care

and Nonhealth Care Workers Undergoing Cataract Surgery, Clinical Ophthalmology,

December 2010.

68. Bucci, F.A., Jr., Four Errors in Prescribing Antibiotics, Cataract and Refractive Surgery

Today, February 2011.

69. Bucci, F.A., Jr., Omega-3 and Dry Eye: Looking at Science and Clinical Experience,

EyeWorld, October, 2012.

70. Bucci, F.A., Jr., Talking NSAIDs for Phacoemulsification, EyeWorld, October, 2012.

71. Bucci, F.A., Jr., The Differences in My Phaco Technique With Laser Cataract Surgery,

Cataract and Refractive Surgery Today Europe, October 2012.

72. Bucci, FA, Jr., Upside Down Multifocal IOL, Cataract and Refractive Surgery Today,

January 2013.

73. Bucci, FA, Jr., Can an Intracameral Mydriatic Combination Reduce Need for Pupil

Expanders?, Ophthalmology Times, July 15, 2016.

30

CURRICULUM VITAE - Bucci Laser VisionASCRS) Symposium, San Diego, CA, April, 2007 Best Poster of...

Documents

Transcript of CURRICULUM VITAE - Bucci Laser VisionASCRS) Symposium, San Diego, CA, April, 2007 Best Poster of...